Financial profile · Q3 FY2026

A growing, low-margin health-services platform with steady cash generation

Cigna has expanded revenue across pharmacy-benefit and health-coverage services, while operating margins remain narrow relative to its large revenue base. It generally generates operating cash well above capital spending, although cash conversion varies with working-capital timing.

What is developing

Revenue continued to grow, while reported quarterly earnings declined largely because the year-earlier comparison included an after-tax gain on a business sale; adjusted operating earnings were broadly stable. Quarterly cash conversion remained volatile, but trailing cash generation stayed positive, indicating movement within the existing model rather than a clear change in its economics.

What matters next

Whether Pharmacy Benefit Services contribution stabilizes as large client renewals and the transition to its Signature model progress.

USD
Metric FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
39.7B 42B 48.4B 153.6B 160.2B 174.1B 180.5B 195.3B 247.1B 274.9B
(27B) (27.7B) (32.3B) (128.5B) (136.2B) (151.1B) (157B) (170.1B) (221.2B) (249.3B)
12.7B 14.3B 16.1B 25.1B 24B 23B 23.5B 25.2B 26B 25.6B
(9.7B) (10B) (11.4B) (16.2B) (15.6B) (14.7B) (14.9B) (16.1B) (16.3B) (15.3B)
— (9.9B) (10.8B) (12.8B) (13.1B) (12.7B) (13B) (14.3B) (14.6B) (13.6B)
(151m) (115m) (235m) (2.9B) (2B) (2B) (1.9B) (1.8B) (1.7B) (1.7B)
(9.6B) — (406m) (483m) (502m) — — — — —
3B 4.3B 4.7B 8.9B 8.4B 8.3B 8.6B 9B 9.7B 10.3B
— (252m) (271m) (1.5B) (1.3B) (1B) (1.7B) (1.5B) (4B) (1.4B)
— 252m 271m 1.7B 1.4B 1.2B 1.2B 1.4B 1.4B 1.4B
(35m) (447m) (877m) (812m) 3.7B (451m) 1.5B (2B) (433m) (1B)
3B 3.6B 3.6B 6.6B 10.9B 6.8B 8.4B 5.5B 5.3B 7.8B
(1.1B) (1.1B) (939m) (1.5B) (2.4B) (1.4B) (1.6B) (141m) (1.5B) (1.5B)
1.8B 2.5B 2.6B 5.1B 8.5B 5.4B 6.8B 5.4B 3.8B 6.3B
24m 5m (9m) (16m) (31m) (50m) (78m) (208m) (344m) (331m)
1.9B 2.2B 2.6B 5.1B 8.5B 5.4B 6.7B 5.2B 3.4B 6B
7.19 8.77 10.52 13.44 22.96 15.75 21.41 17.39 12.12 22.18